vascular dementia: A degenerative vascular disorder affecting the brain. It is caused by the blockage of the blood supply to the brain. It is manifested with decline of memory and cognitive functions.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
318 |
4. Check minimum number of eventsNone |
318 |
5. Include endpointsNone |
318 |
6. Filter based on genotype QC (FinnGen only) |
275 |
Control definitions (FinnGen only)
- Control exclude
- F5_DEMENTIA, G6_ALZHEIMER, G6_AD_STRICT
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F01
- Name in latin
- Alia dementia vascularis specificata
Similar endpoints
↥List of similar endpoints to
Vascular dementia (other)
based on the number of shared cases.
Similar with more cases:
- Vascular dementia
- Any dementia
- Any dementia, excluding more controls
- Dementia
- Dementia, including avohilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 275 | 121 | 154 |
| Unadjusted period prevalence (%) | 0.06 | 0.04 | 0.07 |
| Median age at first event (years) | 83.16 | 84.06 | 82.46 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 284
- Matched controls
- 2840
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N06DX01
ATC
memantine; oral
94.5
161.9
86
13
F01.8
ICD-10 Finland
Other vascular dementia
+∞
134.3
118
*
N05AX08
ATC
risperidone; systemic
18.9
119.3
113
96
F03
ICD-10 Finland
Unspecified dementia
38.0
100.9
65
22
F01.80
ICD-10 Finland
Other specified vascular dementia without additional symptoms
+∞
85.9
78
*
F01.9
ICD-10 Finland
Vascular dementia, unspecified
868.5
71.3
67
*
N06DA02
ATC
donepezil; oral
30.9
59.2
40
15
F01.89
ICD-10 Finland
Other specified vascular dementia without information on additional symptoms
+∞
53.9
50
*
N05AH04
ATC
quetiapine; oral
7.6
51.3
90
163
F01.84
ICD-10 Finland
Other specified vascular dementia other mixed symptoms of mixed type
+∞
45.0
42
*
P20
ICPC
Memory disturbance
5.4
40.8
113
309
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
6.5
39.6
79
160
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
5.4
35.0
89
223
N06DA04
ATC
galantamine; oral
198.7
34.6
35
*
R41.0
ICD-10 Finland
Disorientation, unspecified
9.9
31.8
39
45
N05AH03
ATC
olanzapine; systemic
11.5
29.4
32
31
G30.1
ICD-10 Finland
Alzheimer disease with late onset
41.2
26.8
33
9
SPAT1053
SPAT
Memory test
4.0
26.6
107
374
F01.81
ICD-10 Finland
Other specified vascular dementia has other additional symptoms, mainly paranoidism
+∞
25.4
24
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.6
25.2
167
803
R53
ICD-10 Finland
Malaise and fatigue
3.6
25.2
131
540
N03AG01
ATC
valproic acid; systemic, rectal
7.8
23.9
35
50
N06AX11
ATC
mirtazapine; oral
3.4
22.9
137
610
A28
ICPC
Limited function/disability NOS
3.4
22.6
132
577
SPAT1216
SPAT
Assessment of functional ability
3.7
22.6
101
373
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
8.7
22.6
30
38
AA1AD
NOMESCO Finland
CT of head and brain
3.4
22.5
153
733
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.4
22.5
134
593
N06DA03
ATC
rivastigmine; oral, transdermal
68.2
22.2
25
*
R41.3
ICD-10 Finland
Other amnesia
9.0
21.8
28
34
F05.9
ICD-10 Finland
Delirium, unspecified
8.8
21.3
28
35
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
+∞
21.1
20
*
G30.8
ICD-10 Finland
Other Alzheimer disease
118.8
20.9
22
*
N05BA04
ATC
oxazepam; oral
3.4
20.7
109
444
SPAT1234
SPAT
Support of social functional capacity
5.4
20.4
44
93
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
4.5
20.2
57
151
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
3.5
20.0
92
343
SPAT1172
SPAT
Guidance concerning hydration
8.2
19.4
27
36
L28
ICPC
Limited function/disability (L)
3.2
19.4
119
527
SPAT1254
SPAT
Administration of medicine
3.3
17.8
87
334
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.9
16.6
56
168
N05AD01
ATC
haloperidol; systemic
6.9
16.1
26
41
F01
ICD-10 Finland
Vascular dementia
168.9
15.6
16
*
N06AB10
ATC
escitalopram; oral
3.7
15.0
54
169
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
4.5
14.6
39
98
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
45.0
14.3
17
*
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.9
13.9
86
372
F01.20
ICD-10 Finland
Subcortical vascular dementia without additional symptoms
42.2
13.3
16
*
F05.1
ICD-10 Finland
Delirium superimposed on dementia
52.5
13.0
15
*
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
3.4
12.8
53
181
N06AB04
ATC
citalopram; systemic
2.8
12.6
77
330
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.4
12.2
25
50
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
11.3
12.0
22
21
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.0
11.9
27
59
N02AA05
ATC
oxycodone; systemic
2.5
11.7
98
489
G40.9
ICD-10 Finland
Epilepsy, unspecified
6.0
11.7
21
37
W19
ICD-10 Finland
Unspecified fall
3.2
11.6
51
180
F01.29
ICD-10 Finland
Subcortical vascular dementia without information on additional symptoms
+∞
11.5
11
*
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
+∞
11.5
11
*
F01.82
ICD-10 Finland
Other specified vascular dementia other additional symptoms, mainly hallucinations
124.9
11.5
12
*
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
3.9
11.3
35
98
F06.7
ICD-10 Finland
Mild cognitive disorder
5.0
11.2
25
54
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
14.7
11.1
18
13
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.6
10.8
81
382
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.9
10.6
33
93
F01.83
ICD-10 Finland
Other specified vascular dementia other additional symptoms, mainly depression
+∞
10.5
10
*
U04
ICPC
Incontinence urine
3.5
10.5
39
124
P70
ICPC
Dementia
11.2
10.4
19
18
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.5
10.3
83
404
SPAT1360
SPAT
Extensive global examination
3.8
10.2
33
95
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
4.1
10.2
29
76
A04
ICPC
Weakness/tiredness general
2.6
10.2
72
328
N06AX26
ATC
vortioxetine; oral
5.3
10.2
21
42
N02BE01
ATC
paracetamol; systemic, rectal
3.5
10.1
256
2050
N30.0
ICD-10 Finland
Acute cystitis
2.6
9.9
69
312
SPAT1245
SPAT
Provision of support and information to patient’s family members
4.0
9.9
29
78
S01.0
ICD-10 Finland
Open wound of scalp
3.2
9.8
42
146
F01.2
ICD-10 Finland
Subcortical vascular dementia
57.0
9.7
11
*
F22.0
ICD-10 Finland
Delusional disorder
18.3
9.5
14
8
F01.3
ICD-10 Finland
Mixed cortical and subcortical vascular dementia
103.3
9.5
10
*
SPAT1215
SPAT
Assessment of need for medical rehabilitation
5.0
9.5
21
45
SPAT1167
SPAT
Insertion of urinary catheter
4.2
9.1
25
64
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.9
9.1
47
182
P03
ICPC
Feeling depressed
4.6
8.8
21
48
F01.30
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without additional symptoms
51.6
8.7
10
*
A06AD11
ATC
lactulose; oral
2.3
8.4
81
422
F01.10
ICD-10 Finland
Multi-infarct dementia without additional symptoms
+∞
8.4
8
*
A98
ICPC
Health maint/preventive medicine
2.7
8.2
242
1943
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.8
8.1
43
168
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
34.4
8.1
10
*
N30.9
ICD-10 Finland
Cystitis, unspecified
3.1
7.9
34
118
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
3.8
7.9
25
71
K90
ICPC
Stroke/cerebrovascular accident
4.2
7.8
21
53
I95.1
ICD-10 Finland
Orthostatic hypotension
3.3
7.7
31
103
R55
ICD-10 Finland
Syncope and collapse
2.4
7.7
58
270
J01DB01
ATC
cefalexin; oral
2.2
7.3
221
1737
I10
ICD-10 Finland
Essential (primary) hypertension
2.3
7.3
224
1771
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
7.2
125
808
SPAT1301
SPAT
No procedures
2.0
7.2
109
672
S06.0
ICD-10 Finland
Concussion
2.7
7.0
39
157
N05BA06
ATC
lorazepam; systemic, sublingual
3.4
6.9
25
78
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.3
6.9
61
305
ZXD35
NOMESCO Finland
Usual procedure
4.5
6.8
17
40
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.5
6.8
46
204
S72.0
ICD-10 Finland
Fracture of neck of femur
2.9
6.7
32
118
SPAT1229
SPAT
Assessment of need for aid
2.5
6.5
42
181
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.1
6.5
72
392
Z02.7
ICD-10 Finland
Issue of medical certificate
3.0
6.4
30
109
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.5
6.4
43
190
F01.1
ICD-10 Finland
Multi-infarct dementia
+∞
6.3
6
*
F00.20
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
+∞
6.3
6
*
F01.19
ICD-10 Finland
Multi-infarct dementia without information on additional symptoms
+∞
6.3
6
*
F01.0
ICD-10 Finland
Vascular dementia of acute onset
+∞
6.3
6
*
N29
ICPC
Neurological sympt/complt other
12.9
6.1
10
8
130
Kela drug reimbursment
Malignant tumour
0.2
6.1
*
247
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
6.0
64
343
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
141
539
4.21
31.75
2.3
1.7
1020.45
1168.33
nmol/l
1.12
103
415
204
1259
3.20
17.84
7.3
7.0
1.22
1.21
mmol/l
1.63
165
1076
186
1135
2.85
15.76
7.1
6.4
1.22
1.21
mmol/l
0.85
163
1034
183
1113
2.81
15.51
3.1
2.4
86.69
93.20
pmol/l
1.05
99
594
107
519
2.70
13.90
2.3
1.9
—
—
—
0
0
174
1103
2.49
12.44
3.8
4.9
32.98
33.87
g/l
1.17
147
1025
140
822
2.39
11.64
2.4
3.3
2.36
2.36
mmol/l
0.08
110
730
136
795
2.36
11.35
2.7
2.2
—
—
—
0
0
129
739
2.37
11.25
2.8
2.5
2.67
3.07
mg/l
1.26
102
631
247
1904
3.28
11.13
31.3
22.1
28.35
28.70
mg/l
0.07
236
1691
230
1726
2.75
10.53
6.1
5.4
2.01
2.12
mu/l
0.49
202
1533
145
913
2.20
9.68
5.0
4.0
—
—
—
0
0
194
1376
2.29
9.58
7.5
5.0
7.25
6.92
mmol/l
1.13
186
1325
248
1973
3.03
9.41
42.3
33.5
4.21
4.27
e12/l
0.78
239
1927
248
1973
3.03
9.41
42.7
33.5
235.68
233.13
e9/l
0.27
242
1932
248
1973
3.03
9.41
43.5
34.0
37.93
38.51
%
0.82
243
1943
184
1289
2.21
9.20
22.8
23.2
1.48
1.45
inr
0.25
160
1105
159
1055
2.15
9.10
3.7
3.0
51.09
60.93
u/l
0.66
143
969
196
1421
2.22
8.81
4.3
4.2
15.58
15.27
pmol/l
0.91
167
1255
156
1043
2.10
8.57
6.1
4.9
50.13
111.10
ng/l
0.53
129
874
77
394
2.31
8.33
2.3
1.8
—
—
—
0
0
38
140
2.98
7.98
1.7
1.4
—
—
—
0
0
48
202
2.66
7.88
1.8
1.6
—
—
—
0
0
142
939
2.02
7.81
2.6
2.4
78.95
80.90
nmol/l
0.30
118
822
32
112
3.09
7.33
2.2
2.0
—
—
—
0
0
238
1937
2.41
7.13
11.9
13.0
25.92
23.37
u/l
0.26
227
1873
117
748
1.96
6.86
4.8
3.9
0.71
0.46
e6/l
0.51
91
595
210
1640
2.08
6.78
7.1
7.9
78.91
85.13
u/l
1.29
195
1550
70
373
2.16
6.73
2.2
1.8
—
—
—
0
0
29
101
3.08
6.70
2.2
1.8
—
—
—
0
0
169
1235
1.91
6.50
4.2
5.8
11.81
12.93
umol/l
0.61
161
1180
120
785
1.92
6.49
2.3
1.9
17.69
20.91
nmol/l
1.26
102
656
135
925
1.88
6.27
3.1
3.3
119.11
153.40
ug/l
1.34
116
839
197
1530
1.94
6.12
4.9
4.6
16.84
17.31
mm/h
0.12
178
1395
87
530
1.92
5.70
4.9
4.7
104.84
225.03
ng/l
1.04
79
479
11
13
8.75
5.61
2.7
2.3
—
—
—
0
0
139
987
1.80
5.55
2.9
3.3
—
—
estimate
—
0
0
26
96
2.88
5.44
1.1
4.2
4.52
3.23
ratio
0.22
16
55
88
546
1.89
5.42
2.9
3.3
2.50
2.49
mmol/l
0.46
64
482
10
11
9.37
5.33
1.1
1.0
—
—
—
0
0
14
27
5.40
5.15
1.4
1.2
3.43
98.68
e6/l
—
7
22
14
27
5.40
5.15
1.4
1.1
53.43
3.50
e6/l
—
7
22
27
105
2.74
5.14
1.1
4.4
56.98
118.15
mg/l
0.52
20
91
27
105
2.74
5.14
1.1
4.5
28.96
59.23
mg/l
0.74
20
91
21
71
3.11
5.10
1.2
1.4
—
—
—
0
0
21
71
3.11
5.10
1.2
1.4
—
—
—
0
0
72
426
1.92
5.08
4.5
3.6
2.68
1.77
e6/l
0.34
36
237
41
196
2.28
5.08
2.2
1.8
—
—
—
0
0
75
455
1.88
4.89
4.3
3.5
0.77
1.24
e6/l
1.59
41
263
87
560
1.80
4.67
2.2
1.9
453.61
12418754.20
pmol/l
0.50
75
459
214
1776
1.83
4.61
8.3
7.9
43.76
41.56
mmol/mol
1.78
186
1615
7
5
14.30
4.60
1.7
2.0
—
—
—
0
0
7
5
14.30
4.60
1.0
1.0
—
—
—
0
0
7
5
14.30
4.60
1.7
2.0
—
—
—
0
0
160
1232
1.68
4.43
5.0
8.4
5.26
4.53
e9/l
2.54
126
1062
19
67
2.97
4.31
1.6
1.3
246.89
295.41
ug/g
—
9
37
213
1780
1.79
4.30
30.3
22.9
64.08
64.75
ml/min/173m2
0.19
200
1699
79
506
1.78
4.27
2.0
2.6
9.00
11.34
umol/l
3.21
67
472
59
349
1.87
4.11
1.3
1.2
0.73
1.12
u/ml
—
9
86
149
1142
1.64
4.08
5.8
5.2
0.09
0.01
estimate
0.38
34
269
23
93
2.60
4.08
2.3
2.8
4.35
4.16
pmol/l
0.24
13
82
24
100
2.53
4.01
1.4
1.2
—
—
—
0
0
74
473
1.76
4.00
2.0
2.6
2.30
2.22
g/l
0.53
62
439
181
1461
1.66
4.00
35.1
28.1
14.36
14.27
%
0.37
181
1446
30
139
2.30
4.00
1.7
1.7
2.83
3.06
ug/l
0.03
21
118
8
11
7.45
3.88
1.1
1.0
—
—
—
0
0
214
1814
1.73
3.84
5.6
6.1
6.35
6.21
mmol/l
0.53
182
1608
47
265
1.93
3.78
2.6
2.7
3.81
5.92
ug/l
0.98
29
236
147
1138
1.60
3.76
5.8
5.2
0.00
5.62
estimate
0.50
35
289
6
6
10.18
3.51
1.0
1.0
—
—
—
0
0
64
409
1.73
3.43
2.0
2.8
0.82
0.82
mmol/l
0.07
50
380
98
706
1.59
3.29
2.4
2.5
56.67
64.84
u/l
0.56
90
654
143
1123
1.55
3.29
5.8
5.1
0.00
0.00
estimate
-0.00
33
277
36
196
1.96
3.20
1.8
1.8
454.69
416.12
nmol/l
0.41
29
176
82
569
1.62
3.20
2.3
2.8
—
—
—
0
0
52
319
1.77
3.20
2.4
3.6
2.10
1.72
mmol/l
0.29
44
257
211
1824
1.61
3.06
5.5
6.4
2.16
2.35
mmol/l
2.56
183
1627
44
689
0.57
2.94
1.7
1.9
1.27
1.23
mmol/l
0.19
39
541
11
33
3.43
2.84
1.5
1.3
—
—
—
0
0
11
33
3.43
2.84
1.5
1.3
—
—
—
0
0
54
348
1.68
2.79
7.7
6.0
0.92
1.16
mmol/l
0.22
38
282
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
6
8.45
2.76
1.4
1.0
—
—
—
0
0
11
34
3.32
2.76
2.5
1.5
—
—
—
0
0
65
444
1.60
2.67
2.1
2.7
16.88
21.01
%
2.18
54
419
41
248
1.76
2.65
1.8
2.3
7.85
9.72
umol/l
0.32
33
211
15
63
2.46
2.51
1.3
1.2
—
—
—
0
0
10
32
3.20
2.46
1.3
1.3
—
—
—
0
0
43
271
1.69
2.41
5.4
4.1
—
—
—
0
0
52
345
1.62
2.40
7.8
6.0
4.96
5.13
kpa
0.45
45
331
5
8
6.34
2.38
1.4
1.0
—
—
—
0
0
5
8
6.34
2.38
1.4
1.0
—
—
—
0
0
29
163
1.87
2.38
1.3
1.7
1.57
1.63
g/l
0.17
19
152
52
346
1.62
2.37
7.8
6.0
10.58
11.39
kpa
0.51
45
332
29
167
1.82
2.21
4.6
4.1
2.96
1.74
mmol/l
0.76
17
126
32
191
1.76
2.18
2.7
2.6
28.32
32.11
u/l
0.62
25
160
198
1744
1.45
2.14
4.7
5.4
1.37
1.41
mmol/l
0.75
169
1549
83
628
1.45
2.10
2.7
2.8
33.65
41.82
u/l
0.75
78
598
9
31
2.96
2.09
1.6
1.3
—
—
—
0
0
9
31
2.96
2.09
1.6
1.3
—
—
—
0
0
199
1763
1.43
2.02
4.7
5.4
4.00
4.21
mmol/l
1.94
172
1586
9
32
2.87
2.02
1.6
1.3
—
—
—
0
0
191
1684
1.41
1.96
4.1
4.5
1.22
1.24
mmol/l
0.17
159
1477
54
380
1.52
1.94
2.9
4.9
1.02
1.07
mmol/l
0.42
46
355
26
153
1.77
1.87
9.8
7.2
25.91
24.60
mmol/l
0.72
26
153
78
595
1.43
1.87
6.4
4.8
0.00
0.01
estimate
0.50
28
222
21
116
1.88
1.84
1.7
2.5
3.23
3.07
g/l
0.29
15
102
23
131
1.82
1.84
5.0
3.9
1.53
1.55
%
0.06
23
123
5
12
4.22
1.83
2.0
1.2
—
—
—
0
0
20
109
1.90
1.82
1.7
2.6
10.83
10.44
g/l
0.13
13
94
103
832
1.37
1.76
5.8
6.3
2.18
4.34
ug/l
1.53
84
730
19
104
1.89
1.72
1.8
2.6
1.24
0.93
g/l
0.12
14
86
34
224
1.59
1.64
2.7
3.8
85.19
98.90
ng/l
0.66
27
191
6
20
3.04
1.59
1.0
1.5
—
—
—
0
0
13
64
2.08
1.56
1.0
1.0
—
—
—
0
0
21
125
1.73
1.48
1.7
2.4
3.67
3.53
g/l
0.31
15
111
21
125
1.73
1.48
1.7
2.4
7.56
7.59
g/l
0.03
15
111
21
125
1.73
1.48
1.7
2.4
4.30
4.14
g/l
0.43
14
111
7
28
2.54
1.46
1.1
1.2
—
—
—
0
0
124
1054
1.31
1.45
3.6
3.7
2796.92
2342.47
ng/l
0.47
103
945
55
413
1.41
1.43
6.9
6.1
104.04
103.42
mmol/l
0.38
55
413
37
258
1.50
1.41
1.8
2.7
64.67
65.22
g/l
0.15
28
233
19
112
1.75
1.39
4.1
3.2
0.78
0.88
nmol/l
0.44
12
92
6
23
2.64
1.37
1.7
1.5
—
—
—
0
0
38
269
1.48
1.35
11.9
9.0
—
—
—
0
0
33
227
1.51
1.34
1.6
2.1
0.21
0.19
g/l
0.45
25
208
82
668
1.32
1.28
4.8
5.0
22.06
22.01
%
0.01
38
372
101
849
1.29
1.25
6.6
5.5
0.00
0.04
estimate
1.49
28
236
9
169
0.52
1.23
1.2
1.4
—
—
—
0
0
37
266
1.45
1.22
2.9
5.7
11.28
13.41
mmol/l
0.54
32
250
37
266
1.45
1.22
5.2
5.5
34.36
33.81
%
0.10
22
158
5
19
2.66
1.22
1.0
1.5
—
—
—
0
0
60
470
1.35
1.22
1.4
1.6
1.80
1.67
mg/l
0.14
51
384
13
71
1.87
1.21
1.2
1.2
—
—
—
0
0
47
355
1.39
1.19
1.5
3.6
255.97
251.10
u/l
0.08
38
337
61
484
1.33
1.14
3.8
3.4
0.69
0.93
ug/l
1.75
40
338
12
66
1.85
1.10
1.3
1.2
—
—
—
0
0
5
21
2.40
1.09
1.8
1.4
—
—
—
0
0
10
52
1.96
1.07
1.3
1.4
—
—
—
0
0
10
52
1.96
1.07
1.4
1.5
—
—
—
0
0
12
67
1.83
1.06
1.3
1.2
—
—
—
0
0
7
34
2.08
1.03
1.6
1.4
—
—
—
0
0
40
303
1.37
1.01
3.7
3.8
5.08
47.46
ug/l
1.02
35
265
61
494
1.30
0.99
6.0
5.8
1.02
1.02
kg/l
0.01
45
340
5
23
2.19
0.98
2.6
2.5
—
—
—
0
0
5
23
2.19
0.98
1.8
1.4
—
—
—
0
0
13
78
1.70
0.93
5.5
4.0
3.14
1.65
index
—
7
46
11
63
1.78
0.91
1.4
1.4
—
—
—
0
0
71
593
1.26
0.91
2.6
3.0
381.47
376.42
umol/l
0.12
55
504
8
42
1.93
0.89
1.5
1.5
—
—
—
0
0
6
30
2.02
0.87
1.7
1.4
—
—
—
0
0
6
33
1.84
0.79
2.7
3.1
15.33
51.16
u/ml
—
6
33
78
677
1.21
0.70
5.4
5.2
0.00
0.01
estimate
0.50
28
248
93
821
1.20
0.70
3.8
4.2
8.72
11.72
mg/mmol
0.45
53
552
7
42
1.68
0.69
1.9
1.3
—
—
—
0
0
7
44
1.61
0.65
1.9
1.3
—
—
—
0
0
5
30
1.68
0.61
1.2
4.3
—
23.19
—
0
16
0
20
0.00
0.60
0.0
2.8
—
99.34
—
0
20
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
0
21
0.00
0.60
0.0
2.6
—
0.71
—
0
21
6
35
1.73
0.58
1.2
1.5
—
—
—
0
0
6
38
1.59
0.54
1.2
1.1
—
—
—
0
0
9
61
1.49
0.54
1.4
1.4
—
—
—
0
0
11
74
1.51
0.54
1.5
1.5
—
—
—
0
0
23
281
0.80
0.41
1.1
1.3
28.73
41.33
iu/ml
—
6
102
5
33
1.52
0.41
1.6
2.4
228.40
238.82
%
—
5
33
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
11
79
1.41
0.41
2.5
1.4
—
—
—
0
0
14
182
0.76
0.40
3.4
3.3
56.60
50.76
ml/min/173m2
—
5
87
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
5
37
1.36
0.37
1.0
1.1
—
—
—
0
0
6
41
1.47
0.36
1.2
2.0
90.50
82.29
%
—
6
41
13
101
1.30
0.32
3.4
2.5
—
—
—
0
0
7
52
1.35
0.31
1.9
1.3
—
—
—
0
0
9
73
1.24
0.25
1.6
1.4
—
—
—
0
0
5
39
1.29
0.23
2.2
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
27.53
—
0
11
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
36.28
—
0
10
0
10
0.00
0.21
0.0
2.9
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
324.71
—
0
7
20
174
1.16
0.20
4.8
3.9
42.42
46.31
%
0.34
20
166
8
70
1.15
0.16
1.1
1.4
—
—
—
0
0
13
150
0.86
0.15
1.1
1.2
—
—
—
0
0
10
118
0.84
0.14
1.0
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
106
1.14
0.10
3.7
2.2
0.44
0.41
iu/ml
—
6
62
5
45
1.11
0.10
1.0
1.3
—
—
—
0
0
5
46
1.09
0.09
1.2
1.2
—
1.98
—
0
6
24
227
1.06
0.06
2.8
2.8
0.64
0.95
e6/l
0.25
24
217
15
145
1.04
0.00
9.1
4.9
1.02
1.02
ratio
0.15
15
136
0
5
0.00
-0.00
0.0
17.2
—
5.10
—
0
5
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
8.57
—
0
5
0
9
0.00
-0.00
0.0
3.6
—
174.44
—
0
9
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
1065.57
—
0
7
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: VD_O – Vascular dementia (other)
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).